Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeHologic Inc.Hologic Launches its First Cart-Based Ultrasound System, SuperSonic™ MACH 40

Hologic Launches its First Cart-Based Ultrasound System, SuperSonic™ MACH 40

Today announced today the U.S. launch of the SuperSonic™ MACH 40 ultrasound system, expanding the Company’s suite of ultrasound technologies with its first premium, cart-based system. The new system features excellent image quality, standard-setting imaging modes, and is designed to enhance efficiency and accuracy.

“As the leader in breast imaging, we’re committed to delivering insight-driven solutions that optimize patient care across the full continuum of care for breast health – from screening to treatment,” said Pete Valenti, Hologic’s Division President, Breast and Skeletal Health Solutions. “With the addition of the SuperSonic MACH 40 system, we’ve successfully built a comprehensive portfolio of innovative, standard-setting breast ultrasound solutions designed to better meet the needs of breast imagers. The SuperSonic MACH 40 system embodies our commitment to delivering future-oriented solutions and was designed to help healthcare professionals reduce unnecessary biopsies by eliminating re-scans, reducing lesion correlation time, and improving overall diagnostic accuracy.”

The SuperSonic MACH 40 system leverages exclusive UltraFast™ imaging technology – inspired by cutting-edge graphics innovations from the video gaming industry – to provide greater frame rates of up to 20,000 images per second1. The technology also enables innovative imaging modes, without the trade-offs present in conventional systems. This forward-thinking, powerful architecture primes the system for future integrations and AI-driven innovations.

The new system is further enhanced by exceptional B-mode imaging technology, which helps improve diagnostic confidence thanks to smoother images with reduced speckle, clearer images across all tissue densities, and improved lesion conspicuity. It also features the third generation of shear wave-based elastography technology, ShearWave™ PLUS, which provides additional diagnostic information that may help with patient management, including diagnostic workup of breast lesions, lesion targeting during ultrasound-guided biopsy, and lesion size measurement. Three innovative imaging modes come together in TriVu™ imaging, where morphology, stiffness and blood flow can all be analyzed simultaneously in the same image.

“Hologic continues to expand its portfolio with the patient and clinician in mind, and that’s apparent with the recent SuperSonic Imagine acquisition and new innovations,” said Stacy Smith-Foley, MD, Medical Director of The Breast Center at CARTI in Little Rock, AR. “The result has been a consistently growing suite of tools that truly complement each other and help me and my colleagues to efficiently care for our patients on a day-to-day basis across the entire breast health continuum.”

Clinicians performing precision-dependent ultrasound-guided biopsies with the SuperSonic MACH 40 system can also enjoy enhanced control with Needle PL.U.S. imaging, which enables visualization of both the biopsy needle and anatomical structures in real time and predicts the needle trajectory.

The SuperSonic MACH 40 system streamlines workflow with intuitive design and enhanced comfort. Thanks to the SonicPad™ multi-touch trackpad, the new system helps physicians focus on imaging without the distractions of unnecessary user movements, thus enhancing workflow and increasing patient throughput.

The SuperSonic MACH 40 system is part of a growing portfolio of ultrasound solutions resulting from Hologic’s recent acquisition of SuperSonic Imagine, a pioneer in the field of ultrasound imaging. For more information about the SuperSonic MACH 40 ultrasound system, visit hologic.com/ultrasound/MACH-40.


1 Ultrafast Ultrasound Imaging, by Jeremy Bercoff (Published: August 23 2011 DOI: 10.5772/19729)

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy